UM, Pharmaceutical Administration Bureau sign cooperation agreements on third-party technical assessment of proprietary Chinese medicines and testing of Chinese medicine
The University of Macau (UM) and the Pharmaceutical Administration Bureau (ISAF) of the Macao SAR Government have signed a cooperation agreement on third-party technical assessment of proprietary Chinese medicines and a cooperation agreement on third-party testing of Chinese medicine. Under the agreements, both the ...
Delegation from Guangdong-Hong Kong-Macao Greater Bay Area Center for Drug Evaluation and Inspection of NMPA visits UM
A delegation led by Huang Xiaolong, director of the Guangdong-Hong Kong-Macao Greater Bay Area Center for Drug Evaluation and Inspection (GBACDEI) of the National Medical Products Administration (NMPA), visited the University of Macau (UM). The two parties held discussions on strengthening cooperation in the ...
UM holds inaugural Macau International Forum on Pharmaceutical Regulatory Science
The first "Macau International Forum on Pharmaceutical Regulatory Science—High-Quality Development of Traditional Chinese Medicine: Theory and Practice," hosted by the Institute of Chinese Medical Sciences (ICMS) and organized by the Centre for Pharmaceutical Regulatory Sciences (CPRS) at the University of Macau, brought together over ...
UM doctoral students present their study at RAPS Convergence
A study by Shi Junnan and Chen Xianwen, doctoral students in the Institute of Chinese Medical Sciences (ICMS) at the University of Macau (UM), was accepted by the Regulatory Affairs Professionals Society (RAPS). They were invited to present their research at the RAPS Convergence ...
Seminar on FDA regulations and trends in pharmaceuticals products and groundbreaking technologies
Invited by the Centre for Pharmaceutical Regulatory Sciences, University of Macau (CPRS), Dr. Mann Fung, the President of MCF Consulting and an adjunct professor at the Peking University Clinical Research Institute, delivered a seminar titled “Charting New Territories: Evolution of FDA Regulations, Global Interactions, ...
